Sun Pharma arm gets relief from US court in patent infringement case

Massachusetts-based DUSA has been granted preliminary injunctive relief by a federal district court prohibiting defendants Biofrontera Inc, Biofrontera Bioscience GmbH, Biofrontera Pharma GmbH, and Biofrontera AGf from using its confidential and proprietary trade secret information, Sun Pharmaceutical Industries said

Press Trust of India December 26, 2018 17:45:41 IST
Sun Pharma arm gets relief from US court in patent infringement case

New Delhi: Sun Pharma on Wednesday said its arm DUSA Pharmaceuticals has received relief from a US court in a patent infringement case.

Massachusetts-based DUSA has been granted preliminary injunctive relief by a federal district court prohibiting defendants Biofrontera Inc, Biofrontera Bioscience GmbH, Biofrontera Pharma GmbH, and Biofrontera AGf from using its confidential and proprietary trade secret information, Sun Pharmaceutical Industries said in a regulatory filing.

Sun Pharma arm gets relief from US court in patent infringement case

Representational image. Reuters

Earlier this year, DUSA, which is wholly-owned by Sun Pharma, filed a lawsuit against the Biofrontera defendants in the US District Court for the District of Massachusetts.

The lawsuit alleged trade secret misappropriation and patent infringement of DUSA's photodynamic therapy patents covering its product.

DUSA, in its amended complaint filed in July 2018, additionally alleged the Biofrontera defendants misappropriated confidential and trade secret information by obtaining confidential information from its former employees to sell and market defendants' own products.

The lawsuit sought an assessment of both damages and injunctive relief against the Biofrontera defendants, Sun Pharma said.

The court's order prohibits Biofrontera from making use of or disseminating DUSA's sales and financial information, customer lists and customer target lists, training and marketing materials, standard operating procedures, technical information, and unpublished clinical data, and any derivations thereof, effective immediately, it added.

Sun Pharma shares on Wednesday ended 2.23 percent down at Rs 414 apiece on the BSE.

Updated Date:

also read

Top US admiral warns about China's increasingly assertive military actions at Halifax forum
World

Top US admiral warns about China's increasingly assertive military actions at Halifax forum

Admiral John C Aquilino said the US and its allies need to work together more frequently in international waters to build interoperability so they can operate together quickly if needed

China conducts combat readiness drills near Taiwan Strait after US lawmakers' visit
World

China conducts combat readiness drills near Taiwan Strait after US lawmakers' visit

Tensions between Beijing and Washington have soared over the fate of democratic self-ruled Taiwan, which China has vowed to one day retake, by force if necessary.

China's hypersonic missile 'went around the world' in July: Top US military official
World

China's hypersonic missile 'went around the world' in July: Top US military official

China, which confirmed the test on October 18, tried to downplayed it, saying it was "routine test" and emphasised that "it's not missile, but a spacecraft"